| Authors: |
Selewski DT; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Kerr EM; Ripple Effect Communications, Inc, Rockville, MD, USA., Fajardo C; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ, USA., Gillespie BS; International Study of Glomerular Diseases, Florence, MA, USA., Iyer SPN; SeaStar Medical, Denver, CO, USA., Khalid M; Riley Hospital for Children, Indiana University, Bloomington, IN, USA., Komers R; Travere Therapeutics Inc, San Diego, CA, USA., Nakanishi K; Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Ginowan, Okinawa, Japan., Nelson RD; University of Utah Health, Salt Lake City, UT, USA., Oh J; University Medical Center/at Hamburg, Hamburg/Eppendorf, Hamburg, Germany., Schneider B; IgA Nephropathy Foundation, Wall Township, USA., Shah LN; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ, USA., Webb NJ; Swedish Orphan Biovitrum AG, Basel, Switzerland., Zhong X; Peking University First Hospital, Beijing, China., Squillaci G; Kidney Health Initiative, Washington, DC, USA., Lim MD; Kidney Health Initiative, Washington, DC, USA., Trachtman H; Department of Pediatrics, Division of Nephrology, University of Michigan, 1150 W Medical Center Drive, Med Sci 1/ARF 2511, Ann Arbor, MI, 48109-1382, USA. howardtrachtman21@gmail.com. |